Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus type 1 (HIV-1) vaccine designs, but the presence of bNAbs in naturally infected individuals may be associated with high plasma viral loads, suggesting that the magnitude, duration, and diversity of vi...
Egile Nagusiak: | , , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Public Library of Science (PLoS)
2018-01-01
|
Saila: | PLoS ONE |
Sarrera elektronikoa: | https://doi.org/10.1371/journal.pone.0209437 |